|
Adsorbed Tetanus Vaccine BP
Tetanus Toxoid NLT 40 IU/0.5 ml
|
Suspension for injection
|
Tanzania
|
TZ 16 H 0004
|
Registered/Compliant
|
|
BETT
Tetanus Toxoid 0.5 ml/vial
|
Suspension for injection
0.5
|
Tanzania
|
TZ 16 H 0004
|
Registered/Compliant
|
|
BEVAC (HEPATITIS B (rDNA) BP) VACCINE SUSPENSION FOR INJECTION
HEPATITIS B (rDNA) BP
|
HEPATITIS B (rDNA) BP
|
Ghana
|
FDA/HVC/255-04012
|
Valid
|
|
BEtt
TETANUS (ADSORBED)
|
SUSPENSION
40 IU/0.5 ML
|
Zimbabwe
|
2016/18.2/5252
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
Bevac
Hepatitis B Surface Antigen (rDNA) 20 mg/20ml
|
Suspension for injection
|
Tanzania
|
TZ 20 H 0022
|
Registered/Compliant
|
|
COMBE FIVE (LIQUID) -SINGLE DOSE
BORDETELLA PERTUSSIS; DIPTHERIA TOXOID; HAEMOPHILLUS; HEPATITIS B; TETANUS TOXOID
|
INJECTABLE; INJECTION
4IU; 30IU; 11MCG; 12.5MCG; 60IU
|
Zimbabwe
|
2018/18.2/5663
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
COMBE FIVE (LIQUID)-TEN DOSE
BORDETELLA PERTUSSIS; DIPTHERIA TOXOID; HAEMOPHILLUS; HEPATITIS B; TETANUS TOXOID
|
INJECTABLE; INJECTION
4IU; 30IU; 11MCG; 12.5MCG; 60IU
|
Zimbabwe
|
2018/18.2/5662
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
ComBe Five
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed). 5 ml,Hepatitis B Surface antigen protein 12.5 IU,Pertusis (Whole cell) 16 Lf/0.5ml,Purified Capsular Hib polysaccharide 11 IU,Tetanus Toxoid 5.5 q.s to 3.0ml
|
Suspension for injection
DIPHTHERIA TOXOID 25 Q.S TO 3.0 IU + TETANUS TOXOID 5.5 Q.S TO 3.0 IU + PERTUSIS (WHOLE CELL) 16 OU HEPATITIS B SURFACE ANTIGEN PROTEIN 12.5 MCG + PURIFIED CAPSULAR HIB POLYSACCHARIDE 11 MCG/0.5
|
Tanzania
|
TZ 16 H 0219
|
Registered/Compliant
|
|
ComBe Five liquid
B. pertussis (Whole Cell) 16 OU ( _> 4 IU),Diphtheria Toxoid 25 Lf ( _> 30 IU),Purified Capsular Polysaccharide of Hib (PRP) covalently linked to 20 to 36.7 mcg of Tetanus Toxoid 11 mcg,Tetanus Toxoid 5.5 Lf ( _> 60 IU),r-HBsAg 12.5 mcg
|
Suspension for injection
DIPHTHERIA TOXOID 25 Q.S TO 3.0 IU + TETANUS TOXOID 5.5 Q.S TO 3.0 IU + PERTUSIS (WHOLE CELL) 16 OU HEPATITIS B SURFACE ANTIGEN PROTEIN 12.5 MCG + PURIFIED CAPSULAR HIB POLYSACCHARIDE 11 MCG/0.5
|
Tanzania
|
TZ 16 H 0219
|
Registered/Compliant
|
|
DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS
DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS
|
VACCINE
0.5ML (10 DOSE)
|
Zimbabwe
|
2021/18.2/6160
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PRTUSSIS; TETANUS
DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS
|
VACCINE
0.5ML
|
Zimbabwe
|
2021/18.2/6159
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
Diphtheria Tetanus Pertussis (Whole Cell) Hepatitis B (rDNA) and Haemophilus type b conjugate vaccin
Aluminium Phosphate 1.25 mg,B-Pertusis (whole cell) >=16 Lf/0.5ml,Diptheria Toxoid >=25 CCU50,Hepatitis B Surface Antigen (rDNA) 12.5 cc,Purified Capsular Hib polysaccharide 11 ng,Tetanus Toxoid >=5.5 CCU50,Thiomersal 0.01 g/drop
|
Injection
|
Tanzania
|
TZ 15 H 0237
|
Registered/Compliant
|
|
MEASLES AND RUBELLA
Measles Virus 1000 CCID50/0.5ml,Rubella Virus 1000 CCID50/0.5ml
|
Vaccine
|
Tanzania
|
TAN 20 HM 0143
|
Registered/Compliant
|
|
MEASLES AND RUBELLA VACCINE
Measles Virus 1000 CCID50/0.5ml,Rubella Virus 1000 CCID50/0.5ml
|
Vaccine
|
Tanzania
|
TAN 20 HM 0131
|
Registered/Compliant
|
|
MEASLES AND RUBELLA VACCINE (LIVE ATTENUATED) FREEZE DRIED
MEASLES AND RUBELLA (LIVE ATTENUATED)
|
MEASLES AND RUBELLA (LIVE ATTENUATED)
|
Ghana
|
FDA/HVC/255-04011
|
Valid
|
|
PNEUBEVAX 14 (Five dose Vial)
2- Phenoxyethanol 4.0 mg,Adsorbed onto Aluminum Phosphate, as Al+++ 0.75 mg,Pneumococcal Polysaccharide serotype 6B 4.4 mcg,Pneumococcal polysaccharide serotype 1 3.0 mcg,Pneumococcal polysaccharide serotypes 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F 2.2 mcg
|
suspension vaccine
|
Tanzania
|
TAN 26 V 0052
|
Registered/Compliant
|
|
PNEUBEVAX 14 (Single dose Vial)
2- Phenoxyethanol 4 mg,Adsorbed onto Aluminum Phosphate, as Al+++ 0.75 mg,Pneumococcal Polysaccharide serotype 6B 4.4 mcg,Pneumococcal polysaccharide serotype 1 3.0 mcg,Pneumococcal polysaccharide serotypes 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F 2.2 mcg
|
suspension vaccine
|
Tanzania
|
TAN 26 V 0053
|
Registered/Compliant
|
|
TYPHIBEV
2-phenoxyethanol 5 mg/6 mL,Sodium Chloride and Phosphate buffer q.s to 0.5 /ml,Typhoid Vi Polysaccharide Conjugated to 16.7ug to 100 ug of CRM 197 25 micrograms
|
Solution for injection
25
|
Tanzania
|
TAN 22 V 0123
|
Registered/Compliant
|
|
TYPHIBEV
2-phenoxyethanol 5 mg/6 mL,Sodium Chloride and Phosphate buffer q.s to 0.5 /ml,Typhoid Vi Polysaccharide Conjugated to 16.7ug to 100 ug of CRM 197 25 microgram
|
Solution for injection
25
|
Tanzania
|
TAN 22 V 0122
|
Registered/Compliant
|
|
TYPHIBEV VACCINE (TYPHOID CONJUGATE (MONOVALENT)) SOLUTION FOR INJECTION
TYPHOID CONJUGATE (MONOVALENT)
|
TYPHOID CONJUGATE (MONOVALENT)
|
Ghana
|
FDA/HVC/255-04013
|
Valid
|